期刊文献+

人源性脑胶质瘤噬菌体抗体库的构建 被引量:1

CONSTRUCTION OF PHAGE LIBRARY OF HUMAN ANTIBODY FROM GLIOMA PATIENTS
暂未订购
导出
摘要 为构建人源性脑胶质瘤噬菌体抗体库 ,从脑胶质瘤患者外周血淋巴细胞 (PBL)中提取细胞总RNA ,经逆转录后用套式PCR分别扩增抗体轻链Vκ和重链VH基因。先构建Vκ基因库 ,并使连接Vκ和VH基因的linker与Vκ基因连接 ,再将VH基因克隆入Vκ基因库 ,即构建成功单链抗体 (ScFv)库。随机挑取菌落鉴定 ,测序表明从PBL中扩增出人源性Vκ和VH基因 ,并构建了库容量约为 2× 10 6的ScFv噬菌体抗体库。随机挑取克隆的测序表明 ,测定的VH基因与Kabat的抗体基因库中人抗体VH基因有较高的同源性 ,证明所克隆的基因属人抗体可变区基因。结果表明实验构建成人源性脑胶质瘤噬菌体抗体库 。 To construct human antibody repertory with phage display technology. Total RNA was extracted from peripheral blood lymphocytes (PBL) of clinical glioma patients and subjected to reverse transcription PCR. Variable region genes(V κ and V H genes) were amplified from the cDNA using nested polymerase chain reaction. V κ gene library was first constructed and attached to the Linker which could specially connect V κ gene and V H gene, then V H gene was cloned into V κ gene library to build ScFv repertoire. Positive colonies were selected randomly and sequenced. The results implied that amplified human V κ gene and V H gene could be derived from PBL of clinical glioma patients. ScFv phage antibody gene repertoire in about 2×10 6 capacity was successfully constructed. The sequencing indicated that the cloned genes encoded variable regions of heavy chains of human antibody and were highly homologous with human kappa heavy chain group III of Kabat's database. Then human antibody repertoire was successfully constructed with phage display technology. The present study can be used as a foundation for succeeding screening of specific antibody against human glioma.
出处 《解放军医学杂志》 CAS CSCD 北大核心 2001年第11期795-797,共3页 Medical Journal of Chinese People's Liberation Army
基金 国家自然科学基金资助课题 (编号 39970 85 2 )
关键词 神经胶质瘤 噬菌体抗体库 单链抗体 免疫治疗 脑肿瘤 PBL 外周血淋巴细胞 glioma phage antibody repertoire single chain Fv gene
  • 相关文献

参考文献4

  • 1阎岩 徐志凯 等.用套式PCR扩增人抗体可变区基因及其克隆及序列分析[J].中华实验和临床病毒学杂志,1997,11:141-141.
  • 2阎岩,中华实验和临床簿学杂志,1997年,11卷,增刊,141页
  • 3Cai X,Proc Nat Acad Sci USA,1996年,93卷,13期,6280页
  • 4Cai X,Proc Nat Acad Sci USA,1995年,92卷,14期,6537页

共引文献1

同被引文献14

  • 1Yu L,Ju DW,Chen W,et al.131I-chTNT radioimmunotherapy of 43 patients with advanced lung cancer.Cancer Biother Radiopharm,2006,21(1):5.
  • 2Liu A,Hu P,Khawli LA,et al.B7.1/NHS76:a new costimulator fusion protein for the immunotherapy of solid tumors.J Immunother,2006,29(4):425.
  • 3Mizokami MM,Hu P,Khawli LA,et al.Chimeric TNT-3 antibody/murine interferon-gamma fusion protein for the immunotherapy of solid malignancies.Hybrid Hybridomics,2003,22(4):197.
  • 4Biela BH,Khawli LA,Hu P,et al.Chimeric TNT-3/human beta-glucuronidase fusion proteins for antibody-directed enzyme prodrug therapy (ADEPT).Cancer Biother Radiopharm,2003,18(3):339.
  • 5Sharifi J,Khawli LA,Hu P,et al.Characterization of a phage display-derived human monoclonal antibody (NHS76) counterpart to chimeric TNT-1 directed against necrotic regions of solid tumors.Hybrid Hybridomics,2001,20(5-6):305.
  • 6Street HH,Goris ML,Fisher GA,et al.Phase I study of 131I-chimeric(ch) TNT-1/B monoclonal antibody for the treatment of advanced colon cancer.Cancer Biother Radiopharm,2006,21(3):243.
  • 7Shapiro WR,Carpenter SP,Roberts K,et al.(131)I-chTNT-1/B mAb:tumour necrosis therapy for malignant astrocytic glioma.Expert Opin Biol Ther,2006,6(5):539.
  • 8Khawli LA,Alauddin MM,Hu P,et al.Tumor targeting properties of indium-111 labeled genetically engineered Fab' and F(ab')2 constructs of chimeric tumor necrosis treatment (chTNT)-3 antibody.Cancer Biother Radiopharm,2003,18(6):931.
  • 9Velappan N,Martinez JS,Valero R,et al.Selection and characterization of scFv antibodies against the Sin Nombre hantavirus nucleocapsid protein.J Immunol Methods,2007,321(1-2):60.
  • 10Xia J,Bi H,Yao Q,et al.Construction of human ScFv phage display library against ovarian tumor.J Huazhong Univ Sci Technolog Med Sci,2006,26(5):497.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部